Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

24.6%

17 terminated/withdrawn out of 69 trials

Success Rate

59.5%

-27.0% vs industry average

Late-Stage Pipeline

13%

9 trials in Phase 3/4

Results Transparency

40%

10 of 25 completed trials have results

Key Signals

9 recruiting10 with results13 terminated4 withdrawn

Enrollment Performance

Analytics

N/A

27(51.9%)

Phase 2

10(19.2%)

Phase 4

6(11.5%)

Early Phase 1

4(7.7%)

Phase 3

3(5.8%)

Phase 1

2(3.8%)

52Total

N/A(27)

Phase 2(10)

Phase 4(6)

Early Phase 1(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (69)

Showing 20 of 69 trials

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT06639282Phase 2Recruiting

Repurposing Siponimod for Alzheimer's Disease

Role: lead

NCT06581861Recruiting

PREVENT ALL ALS Study

Role: lead

NCT06578195Recruiting

ASSESS ALL ALS Study

Role: lead

NCT06072586Early Phase 1Recruiting

A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions

Role: lead

NCT06332040Phase 4Recruiting

Gentamicin Bladder Instillation on CAUTI

Role: lead

NCT04032626Phase 2Completed

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Role: lead

NCT06429124Not ApplicableRecruiting

Time Restricted Eating in Alzheimer's Disease

Role: lead

NCT03834740Early Phase 1Completed

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

Role: lead

NCT06177028Phase 2Not Yet Recruiting

MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment

Role: lead

NCT06734286Not ApplicableRecruiting

Working Memory Training in Patients with Mild Cognitive Impairment

Role: lead

NCT06019793Not ApplicableEnrolling By Invitation

Electrophysiological Recordings from Deep Brain Stimulation Electrodes for Pain

Role: lead

NCT05925075Enrolling By Invitation

Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress

Role: collaborator

NCT04605263Not ApplicableEnrolling By Invitation

Deep Brain Stimulation (DBS) of the Pedunculopontine Nucleus (PPN)

Role: lead

NCT05276349Completed

Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)

Role: lead

NCT02513914Not ApplicableSuspended

Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial

Role: lead

NCT02389634Completed

Identification of Novel Molecular Markers for Vasospasm

Role: lead

NCT03474614Phase 2Terminated

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Role: lead

NCT02276911Phase 2Terminated

Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery

Role: lead

NCT02386241Terminated

Identification of Genomic Changes in Families Having Multiple Members With Tumors

Role: lead